Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life.
By T. Ng, M. Niti, W. Tan, Zhenying Cao, K. Ong, P. Eng. Archives of Internal Medicine, 2007
679 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Oncology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/4b65ddf807cc1a426e17b41e7e98dd2a1c5eca02
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Oncology
In Pulmonary and Respiratory Medicine
- P. Barnes
- R. Rodríguez-Roisín
- C. Jenkins
- Sonia Buist
- Jan Zieliński
- Yoshinosuke Fukuchi
- Jorgen Vestbo
- S. Hurd
Citations in the corpus
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. (2017, background): “Anxiety and depression are both associated with a poor prognosis.(331,332)”
- Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, background): “Anxiety and depression are major comorbidities in COPD (191– 194), and both are associated with a poor prognosis (193, 195).”
- Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary (2023, neutral): “Both are associated with poor prognosis (181,183), younger age, female sex, smoking, lower FEV1, cough, higher SGRQ score, and a previous history of cardiovascular disease (179,182,184).”
- Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, neutral): “Тревожное расстройство и депрессия являются одними из основных сопутствующих заболеваний при ХОБЛ [117, 497–499] и ухудшают прогноз [498, 500].”